Beranda › Adenokarsinoma Esofagus › New York › Rochester
Uji klinis Adenokarsinoma Esofagus di Rochester, NY
5 studi untuk Adenokarsinoma Esofagus mencari peserta di lokasi sekitar Rochester (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Menerima pesertaFase 2/3
- University of Rochester, Rochester
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Menerima pesertaFase 3
- University of Rochester, Rochester
- Wilmot Cancer Institute at Webster, Webster · 10 mi jauhnya
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
Menerima pesertaFase 2/3
- Local Institution - 0274, Rochester
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Menerima peserta
- University of Rochester Medical Center, Rochester
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
Menerima peserta
- University of Rochester, Rochester
Uji klinis Adenokarsinoma Esofagus di kota lain
- New York City, NY18 studi
- Boston, MA13 studi
- Houston, TX12 studi
- Arlington, VA11 studi
- Nashville, TN11 studi
- Durham, NC10 studi
- Rochester, MN9 studi
- Jacksonville, FL9 studi
- Baldwin Park, CA9 studi
- St. Louis, MO9 studi
- Queens, NY9 studi
- Los Angeles, CA9 studi
Studi lain di Rochester
- Leukemia Mieloid Akut16 studi
- Kanker Paru15 studi
- Kanker Payudara15 studi
- Kanker (semua jenis)14 studi
- Obesitas14 studi
- Kelebihan Berat Badan13 studi
- Kanker Paru Non-Sel Kecil13 studi
- Kanker Prostat10 studi
- Kanker Metastatik8 studi
- Mieloma Multipel8 studi
- Kanker Kandung Kemih7 studi
- Distrofi Miotonik7 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.